Related references
Note: Only part of the references are listed.Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer
Yelena Y. Janjigian et al.
CANCER DISCOVERY (2018)
The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients
Karol Polom et al.
SURGICAL INNOVATION (2018)
Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients
Ari Vanderwalde et al.
CANCER MEDICINE (2018)
Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer
K. Polom et al.
BRITISH JOURNAL OF SURGERY (2018)
Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
Elizabeth D. Thompson et al.
GUT (2017)
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Hypermutation and microsatellite instability in gastrointestinal cancers
Kizuki Yuza et al.
ONCOTARGET (2017)
Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization
Micaela Mathiak et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2017)
Mismatch Repair Deficiency, Microsatellite Instability, and Survival An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial
Elizabeth C. Smyth et al.
JAMA ONCOLOGY (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project
Bo Hwa Sohn et al.
CLINICAL CANCER RESEARCH (2017)
The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing
E. Ryan et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability
Changqing Ma et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Microsatellite Instability as a Biomarker for PD-1 Blockade
Jonathan C. Dudley et al.
CLINICAL CANCER RESEARCH (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
Classification and characterization of microsatellite instability across 18 cancer types
Ronald J. Hanse et al.
NATURE MEDICINE (2016)
CheckMate-032: Phase I/II open-label study of safety and activity of nivolumab (nivo) alone or with ipilimumab (ipi) in advanced and metastatic (A/M) gastric cancer (GC)
Yelena Yuriy Janjigian et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Preliminary safety data from KEYNOTE-059: Pembrolizumab plus 5-fluorouracil (5-FU) and cisplatin for first-line treatment of advanced gastric cancer
Charles S. Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Biliary carcinomas: pathology and the role of DNA mismatch repair deficiency
Vitor Werneck Krauss Silva et al.
CHINESE CLINICAL ONCOLOGY (2016)
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial
N. Normanno et al.
ANNALS OF ONCOLOGY (2015)
Microsatellite instability: an update
Hiroyuki Yamamoto et al.
ARCHIVES OF TOXICOLOGY (2015)
Mismatch Repair-Deficient Cancers Are Targets for Anti-PD-1 Therapy
Sander Kelderman et al.
CANCER CELL (2015)
The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses
Soo Young Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Razvan Cristescu et al.
NATURE MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
J. Goldstein et al.
ANNALS OF ONCOLOGY (2014)
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability
Yakir Segev et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Is Microsatellite Instability a Prognostic Marker in Gastric Cancer?: A Systematic Review With Meta-Analysis
Yoon Young Choi et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs et al.
LANCET (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F. A. Vasen et al.
GUT (2013)
Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes
Joo-Yeun Kim et al.
KOREAN JOURNAL OF PATHOLOGY (2013)
Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection
Ji Yeong An et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair-Defective Colorectal Carcinomas A Report of the Association for Molecular Pathology
William K. Funkhouser et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2012)
Irrelevance of Microsatellite Instability in the Epidemiology of Sporadic Pancreatic Ductal Adenocarcinoma
Luigi Laghi et al.
PLOS ONE (2012)
Genetic Aspects of Gastric Cancer Instability
Petra Hudler
SCIENTIFIC WORLD JOURNAL (2012)
Microsatellite Instability Is Associated With a Better Prognosis for Gastric Cancer Patients After Curative Surgery
Wen-Liang Fang et al.
WORLD JOURNAL OF SURGERY (2012)
Clinicopathologic and Molecular Profiles of Microsatellite Unstable Barrett Esophagus-associated Adenocarcinoma
Alton B. Farris et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Oncogenic mutations in gastric cancer with microsatellite instability
Giovanni Corso et al.
EUROPEAN JOURNAL OF CANCER (2011)
MSI phenotype and MMR alterations in familial and sporadic gastric cancer
Marina Leite et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
DNA Mismatch Repair Deficiency in Ampullary Carcinoma A Morphologic and Immunohistochemical Study of 54 Cases
Narasimhan P. Agaram et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Modulation of mismatch repair and genomic stability by miR-155
Nicola Valeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)
Nicola Valeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Microsatellite Instability Is Associated with the Clinicopathologic Features of Gastric Cancer in Sporadic Gastric Cancer Patients
Shin Hyuk Kim et al.
JOURNAL OF GASTRIC CANCER (2010)
Histopathologic Features and Microsatellite Instability of Cancers of the Papilla of Vater and Their Precursor Lesions
Petra Ruemmele et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Correlation of Microsatellite Instability at Multiple Loci With Long-term Survival in Advanced Gastric Carcinoma
Giovanni Corso et al.
ARCHIVES OF SURGERY (2009)
Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based Approach Versus Molecular Screening
Catherine Julie et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger
Kristin C. Jensen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Molecular Characterization of MSI-H Colorectal Cancer by MLH1 Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening
Jenny N. Poynter et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival
Mario Falchetti et al.
HUMAN PATHOLOGY (2008)
Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers
Vanessa Deschoolmeester et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: A study in different clinical subgroups with and without extracutaneous cancer
Anna Maria Cesinaro et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2007)
Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type
Israel Zighelboim et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers
Kathleen M. Murphy et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers
S Beghelli et al.
SURGERY (2006)
Patterns of genomic instability in gastric cancer: clinical implications and perspectives
L. Ottini et al.
ANNALS OF ONCOLOGY (2006)
Microsatellite instability mutator phenotype in hepatocellular carcinoma in non-alcoholic and non-virally infected normal livers
F Chiappini et al.
CARCINOGENESIS (2004)
Re: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
L Laghi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias
R Kruse et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Evaluation of adult papillary thyroid carcinomas by comparative genomic hybridization and microsatellite instability analysis
AJ Bauer et al.
CANCER GENETICS AND CYTOGENETICS (2002)
Genomic instability measurement in the diagnosis of thyroid neoplasms
DL Stoler et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2002)
Age-related hypermethylation of the hMLH1 promoter in gastric cancers
T Nakajima et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis
T Yoshida et al.
JOURNAL OF GASTROENTEROLOGY (2000)
Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction
KD Berg et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2000)